Chemed [CHE] vs Option Care Health [OPCH] Detailed Stock Comparison

Chemed

Option Care Health
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Chemed wins in 13 metrics, Option Care Health wins in 6 metrics, with 0 ties. Chemed appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Chemed | Option Care Health | Better |
---|---|---|---|
P/E Ratio (TTM) | 22.42 | 21.58 | Option Care Health |
Price-to-Book Ratio | 5.28 | 3.24 | Option Care Health |
Debt-to-Equity Ratio | 12.15 | 90.35 | Chemed |
PEG Ratio | -0.96 | 21.58 | Chemed |
EV/EBITDA | 14.34 | 13.59 | Option Care Health |
Profit Margin (TTM) | 11.56% | 3.93% | Chemed |
Operating Margin (TTM) | 11.00% | 5.84% | Chemed |
EBITDA Margin (TTM) | 11.00% | 5.84% | Chemed |
Return on Equity | 24.14% | 15.25% | Chemed |
Return on Assets (TTM) | 13.56% | 6.20% | Chemed |
Free Cash Flow (TTM) | $367.97M | $287.79M | Chemed |
Dividend Yield | 0.18% | N/A | N/A |
1-Year Return | -26.86% | -9.40% | Option Care Health |
Price-to-Sales Ratio (TTM) | 2.53 | 0.82 | Option Care Health |
Enterprise Value | $6.23B | $5.44B | Chemed |
EV/Revenue Ratio | 2.48 | 1.01 | Option Care Health |
Gross Profit Margin (TTM) | 29.85% | 19.00% | Chemed |
Revenue per Share (TTM) | $170 | $32 | Chemed |
Earnings per Share (Diluted) | $19.45 | $1.26 | Chemed |
Beta (Stock Volatility) | 0.43 | 0.89 | Chemed |
Chemed vs Option Care Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Chemed | -0.32% | -2.40% | -6.77% | -8.52% | -26.64% | -18.29% |
Option Care Health | -0.34% | -3.74% | -8.38% | -12.53% | -20.14% | 18.06% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Chemed | -26.86% | -0.25% | -13.34% | 227.74% | 644.32% | 952.22% |
Option Care Health | -9.40% | -18.44% | 90.75% | 298.81% | 14.73% | 3.08% |
News Based Sentiment: Chemed vs Option Care Health
Chemed
News based Sentiment: MIXED
Chemed experienced a month of mixed signals, with a recent earnings miss and insider selling offset by strategic initiatives and a commitment to shareholder returns. The upcoming Q3 earnings release is a critical catalyst for the stock's future, making this a significant month for investors to assess the company's direction.
Option Care Health
News based Sentiment: MIXED
Option Care Health demonstrated strong financial performance in October with an earnings beat and revised guidance, but a 'Hold' rating from TD Cowen and ongoing contract negotiations with Janssen create a mixed investment picture. The debt refinancing provides financial flexibility, but near-term catalysts appear limited.
Performance & Financial Health Analysis: Chemed vs Option Care Health
Metric | CHE | OPCH |
---|---|---|
Market Information | ||
Market Cap | $6.35B | $4.47B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 198,980 | 2,007,746 |
90 Day Avg. Volume | 201,887 | 1,946,452 |
Last Close | $430.02 | $26.71 |
52 Week Range | $408.42 - $623.61 | $21.39 - $35.53 |
% from 52W High | -31.04% | -24.82% |
All-Time High | $654.62 (Mar 11, 2024) | $91.80 (Apr 22, 2002) |
% from All-Time High | -34.31% | -70.90% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.04% | 0.15% |
Quarterly Earnings Growth | -0.26% | -0.05% |
Financial Health | ||
Profit Margin (TTM) | 0.12% | 0.04% |
Operating Margin (TTM) | 0.11% | 0.06% |
Return on Equity (TTM) | 0.24% | 0.15% |
Debt to Equity (MRQ) | 12.15 | 90.35 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $82.56 | $8.38 |
Cash per Share (MRQ) | $17.22 | $1.27 |
Operating Cash Flow (TTM) | $426.78M | $279.64M |
Levered Free Cash Flow (TTM) | $285.06M | $194.12M |
Dividends | ||
Last 12-Month Dividend Yield | 0.18% | N/A |
Last 12-Month Dividend | $1.00 | N/A |
Valuation & Enterprise Metrics Analysis: Chemed vs Option Care Health
Metric | CHE | OPCH |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 22.42 | 21.58 |
Forward P/E | 17.52 | 21.58 |
PEG Ratio | -0.96 | 21.58 |
Price to Sales (TTM) | 2.53 | 0.82 |
Price to Book (MRQ) | 5.28 | 3.24 |
Market Capitalization | ||
Market Capitalization | $6.35B | $4.47B |
Enterprise Value | $6.23B | $5.44B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.48 | 1.01 |
Enterprise to EBITDA | 14.34 | 13.59 |
Risk & Other Metrics | ||
Beta | 0.43 | 0.89 |
Book Value per Share (MRQ) | $82.56 | $8.38 |
Financial Statements Comparison: Chemed vs Option Care Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CHE | OPCH |
---|---|---|
Revenue/Sales | $646.94M | $1.33B |
Cost of Goods Sold | $430.53M | $1.07B |
Gross Profit | $216.41M | $263.05M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $94.76M | $79.19M |
EBITDA | $112.02M | $93.16M |
Pre-Tax Income | $95.67M | $63.56M |
Income Tax | $23.92M | $16.81M |
Net Income (Profit) | $71.76M | $46.74M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CHE | OPCH |
---|---|---|
Cash & Equivalents | $173.88M | $198.82M |
Total Current Assets | $502.39M | $1.18B |
Total Current Liabilities | $290.56M | $773.62M |
Long-Term Debt | $102.08M | $1.20B |
Total Shareholders Equity | $1.18B | $1.36B |
Retained Earnings | $2.79B | $766.60M |
Property, Plant & Equipment | $724.13M | $134.76M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CHE | OPCH |
---|---|---|
Operating Cash Flow | $34.75M | $-46.97M |
Capital Expenditures | $112,000 | $-9.37M |
Free Cash Flow | $19.46M | $-16.59M |
Debt Repayment | N/A | $-1.63M |
Common Stock Repurchase | $-33.22M | $-100.22M |
Short Interest & Institutional Ownership Analysis
Metric | CHE | OPCH |
---|---|---|
Shares Short | 387,671 | 5.55M |
Short Ratio | 2.17 | 2.93 |
Short % of Float | 0.03% | 0.05% |
Average Daily Volume (10 Day) | 198,980 | 2,007,746 |
Average Daily Volume (90 Day) | 201,887 | 1,946,452 |
Shares Outstanding | 14.56M | 166.26M |
Float Shares | 14.29M | 152.85M |
% Held by Insiders | 0.02% | 0.01% |
% Held by Institutions | 0.98% | 1.02% |
Dividend Analysis & Yield Comparison: Chemed vs Option Care Health
Metric | CHE | OPCH |
---|---|---|
Last 12-Month Dividend | $1.00 | N/A |
Last 12-Month Dividend Yield | 0.18% | N/A |
3-Year Avg Annual Dividend | $1.37 | N/A |
3-Year Avg Dividend Yield | 0.08% | N/A |
3-Year Total Dividends | $4.10 | N/A |
Ex-Dividend Date | Nov 18, 2024 | N/A |